• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Pharmacogenomics Market

    ID: MRFR/LS/14802-HCR
    100 Pages
    MRFR Team
    October 2025

    United States Pharmacogenomics Market Research Report to 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Pharmacogenomics Market Infographic
    Purchase Options

    US Pharmacogenomics Market Summary

    The US Pharmacogenomics market is projected to grow from 12.5 USD Billion in 2024 to 35 USD Billion by 2035, reflecting a robust CAGR of 9.81%.

    Key Market Trends & Highlights

    US Pharmacogenomics Key Trends and Highlights

    • The market valuation is expected to reach 12.5 USD Billion in 2024.
    • By 2035, the market is anticipated to expand to 35 USD Billion.
    • The compound annual growth rate from 2025 to 2035 is projected at 9.81%.
    • Growing adoption of personalized medicine due to increasing awareness of genetic testing is a major market driver.

    Market Size & Forecast

    2024 Market Size 12.5 (USD Billion)
    2035 Market Size 35 (USD Billion)
    CAGR (2025 - 2035) 9.81%

    Major Players

    Apple Inc (US), Microsoft Corp (US), Amazon.com Inc (US), Alphabet Inc (US), Berkshire Hathaway Inc (US), Meta Platforms Inc (US), Tesla Inc (US), Johnson & Johnson (US), Visa Inc (US), Procter & Gamble Co (US)

    Key Companies in the US Pharmacogenomics Market market include

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials